Assessment of morin hydrate as a renal protective agent in rats subjected to methotrexate-induced nephrotoxicity
- 27 November 2024
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 48 (1) , 172-179
Abstract
Methotrexate (MTX) is a generally applied chemotherapeutic medicine in most cancers treatment. Morin hydrate, a robust antioxidant, is a secondary metabolite observed in numerous plants, along with figs, white mulberries, and others. The hypothesis of this study is that morin hydrate can effectively reduce MTX-induced kidney injury in rats by increasing antioxidant enzyme activity and inhibiting apoptotic processes. This study, 35 male Wistar albino rats were used, and five different experimental groups, each consisting of 7 rats were established. Group 1 served as the control group while Group 2 received morin exclusively via oral administration (at a dose of 100 mg/kg). Group 3, however, was administered MTX exclusively (at a dose of 20 mg/kg). Group 4 received a combination of MTX (20 mg/kg) and morin (50 mg/kg), and Group 5 received a combination of MTX (20 mg/kg) and morin (100 mg/kg). The MTX group showed a significant increase in kidney biomarkers, including serum urea, creatinine, and the lipid peroxidation biomarker MDA, compared to the control group, along with a notable decrease in antioxidant enzyme activity (SOD, CAT, GPx) and GSH levels. Furthermore, MTX notably decreased the expression of procas-3, Bcl-2, procas-9, and procas-8 while concurrently increasing the expression of apoptotic genes such as CYT-C and Bax. Co-administration of morin hydrate with MTX at doses of 50 and 100 mg/kg effectively managed oxidative damage levels and apoptotic markers, demonstrating antioxidant and anti-apoptotic properties. Notably, the 100 mg/kg dose provided more robust protection than the 50 mg/kg dose, indicating a dose-dependent efficacy. This investigation thus supports the conclusion that morin hydrate, at both dosage levels, effectively mitigates MTX-induced renal damage.Keywords
Funding Information
- Scientific Research Projects Coordination Unit of Bingol University (BAP-FEF.2021.006)
This publication has 46 references indexed in Scilit:
- Morin attenuated the global cerebral ischemia via antioxidant, anti-inflammatory, and antiapoptotic mechanisms in ratsMetabolic Brain Disease, 2024
- Galangin mitigates oxidative stress, inflammation, and apoptosis in a rat model of methotrexate hepatotoxicityEnvironmental Science and Pollution Research, 2021
- The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectivesPhytotherapy Research, 2021
- Quercetin, chrysin, caffeic acid and ferulic acid ameliorate cyclophosphamide-induced toxicities in SH-SY5Y cellsMolecular Biology Reports, 2020
- The advances of methotrexate resistance in rheumatoid arthritisInflammopharmacology, 2020
- Rebamipide potentially mitigates methotrexate‐induced nephrotoxicity via inhibition of oxidative stress and inflammation: A molecular and histochemical studyThe Anatomical Record, 2020
- RETRACTED ARTICLE: Protective effects of hesperidin against MTX-induced hepatotoxicity in male albino ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Involvement of Nrf2/HO-1 antioxidant signaling and NF-κB inflammatory response in the potential protective effects of vincamine against methotrexate-induced nephrotoxicity in rats: cross talk between nephrotoxicity and neurotoxicityArchives of Toxicology, 2019
- Morin and Its Role in Chronic Diseases2016
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976